Kingworld Medicines Group Limited (1110.HK)
HKD 0.45
(1.12%)
HKD 0.45
(1.12%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.07 Billion CNY | 12.63% |
| 2022 | 957.7 Million CNY | 13.02% |
| 2021 | 847.38 Million CNY | 13.68% |
| 2020 | 745.38 Million CNY | -23.78% |
| 2019 | 977.92 Million CNY | -9.35% |
| 2018 | 1.07 Billion CNY | 4.59% |
| 2017 | 1.03 Billion CNY | -2.09% |
| 2016 | 1.05 Billion CNY | 47.65% |
| 2015 | 713.54 Million CNY | 8.06% |
| 2014 | 660.32 Million CNY | 19.03% |
| 2013 | 554.76 Million CNY | -21.37% |
| 2012 | 705.51 Million CNY | 2.91% |
| 2011 | 685.56 Million CNY | 7.45% |
| 2010 | 638.04 Million CNY | 14.67% |
| 2009 | 556.41 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 263.04 Million CNY | 0.08% |
| 2024 Q2 | 263.04 Million CNY | 0.0% |
| 2023 FY | 1.07 Billion CNY | 12.63% |
| 2023 Q4 | 262.82 Million CNY | 0.0% |
| 2023 Q1 | 276.5 Million CNY | 2.78% |
| 2023 Q3 | 262.82 Million CNY | -4.95% |
| 2023 Q2 | 276.5 Million CNY | 0.0% |
| 2022 Q1 | 209.82 Million CNY | -2.88% |
| 2022 Q3 | 269.02 Million CNY | 28.22% |
| 2022 Q4 | 269.02 Million CNY | 0.0% |
| 2022 FY | 957.7 Million CNY | 13.02% |
| 2022 Q2 | 209.82 Million CNY | 0.0% |
| 2021 FY | 847.38 Million CNY | 13.68% |
| 2021 Q1 | 207.65 Million CNY | -8.21% |
| 2021 Q4 | 216.04 Million CNY | 0.0% |
| 2021 Q3 | 216.04 Million CNY | 4.04% |
| 2021 Q2 | 207.65 Million CNY | 0.0% |
| 2020 Q4 | 226.21 Million CNY | 0.0% |
| 2020 FY | 745.38 Million CNY | -23.78% |
| 2020 Q3 | 226.21 Million CNY | 54.44% |
| 2020 Q2 | 146.47 Million CNY | 0.0% |
| 2020 Q1 | 146.47 Million CNY | -36.16% |
| 2019 Q4 | 229.44 Million CNY | 0.0% |
| 2019 FY | 977.92 Million CNY | -9.35% |
| 2019 Q1 | 259.52 Million CNY | -0.62% |
| 2019 Q3 | 229.44 Million CNY | -11.59% |
| 2019 Q2 | 259.52 Million CNY | 0.0% |
| 2018 FY | 1.07 Billion CNY | 4.59% |
| 2018 Q3 | 261.14 Million CNY | -6.15% |
| 2018 Q2 | 278.27 Million CNY | 0.0% |
| 2018 Q1 | 278.27 Million CNY | 6.54% |
| 2018 Q4 | 261.14 Million CNY | 0.0% |
| 2017 FY | 1.03 Billion CNY | -2.09% |
| 2017 Q4 | 261.18 Million CNY | 0.0% |
| 2017 Q3 | 261.18 Million CNY | 2.61% |
| 2017 Q2 | 254.55 Million CNY | 0.0% |
| 2017 Q1 | 254.55 Million CNY | -19.96% |
| 2016 Q4 | 318.03 Million CNY | 0.0% |
| 2016 Q2 | 208.73 Million CNY | 0.0% |
| 2016 Q3 | 318.03 Million CNY | 52.36% |
| 2016 Q1 | 208.73 Million CNY | 20.46% |
| 2016 FY | 1.05 Billion CNY | 47.65% |
| 2015 Q2 | 183.49 Million CNY | 0.0% |
| 2015 Q3 | 173.27 Million CNY | -5.57% |
| 2015 Q4 | 173.27 Million CNY | 0.0% |
| 2015 FY | 713.54 Million CNY | 8.06% |
| 2015 Q1 | 183.49 Million CNY | 7.53% |
| 2014 FY | 660.32 Million CNY | 19.03% |
| 2014 Q1 | 159.51 Million CNY | 6.28% |
| 2014 Q4 | 170.64 Million CNY | 0.0% |
| 2014 Q2 | 159.51 Million CNY | 0.0% |
| 2014 Q3 | 170.64 Million CNY | 6.97% |
| 2013 Q1 | 127.29 Million CNY | -23.42% |
| 2013 Q3 | 150.08 Million CNY | 17.91% |
| 2013 Q4 | 150.08 Million CNY | 0.0% |
| 2013 FY | 554.76 Million CNY | -21.37% |
| 2013 Q2 | 127.29 Million CNY | 0.0% |
| 2012 FY | 705.51 Million CNY | 2.91% |
| 2012 Q1 | 176.37 Million CNY | 0.0% |
| 2012 Q2 | 176.37 Million CNY | 0.0% |
| 2012 Q4 | 166.21 Million CNY | 0.0% |
| 2012 Q3 | 166.21 Million CNY | -5.76% |
| 2011 Q4 | 176.37 Million CNY | 2.91% |
| 2011 Q2 | 171.39 Million CNY | 0.0% |
| 2011 Q1 | 171.39 Million CNY | 0.0% |
| 2011 FY | 685.56 Million CNY | 7.45% |
| 2011 Q3 | 171.39 Million CNY | 0.0% |
| 2010 Q1 | 159.51 Million CNY | 0.0% |
| 2010 Q4 | 171.39 Million CNY | 7.45% |
| 2010 Q3 | 159.51 Million CNY | 0.0% |
| 2010 Q2 | 159.51 Million CNY | 0.0% |
| 2010 FY | 638.04 Million CNY | 14.67% |
| 2009 FY | 556.41 Million CNY | 0.0% |
| 2009 Q2 | 139.1 Million CNY | 0.0% |
| 2009 Q3 | 139.1 Million CNY | 0.0% |
| 2009 Q4 | 159.51 Million CNY | 14.67% |
| 2009 Q1 | 139.1 Million CNY | 0.0% |
| 2008 Q4 | 139.1 Million CNY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| China Healthwise Holdings Limited | 146.31 Million HKD | -637.207% |
| Tycoon Group Holdings Limited | 1.19 Billion HKD | 10.01% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 1.52 Billion HKD | 29.266% |